Our results indicated that the CD4+ CTL subset expressed PRF1, GZMA, and GZMB, indicating that CD4+ CTLs may induce apoptosis in tumor cells via the release of cytotoxic mediators, especially granzyme B and perforin. This evidence concerns the gene PRF1 and neoplasm.